Questions remain over US CCP liquidity rules

CME has been waiting seven months for its liquidity plans to be approved

CME headquarters

Recent rulemakings from US markets regulators have eased fears that central counterparties (CCPs) would be prevented from counting US Treasury collateral towards their liquidity reserves, but the issue may not have been completely settled, with the Federal Reserve said to have continuing concerns that it could be impossible under some circumstances to immediately liquidate large amounts of securities. CME Group has been waiting since December for both groups of regulators to approve its amended

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

If you already have an account, please sign in here.


Want to know what’s included in our free registration? Click here

This address will be used to create your account

Calibrating interest rate curves for a new era

Dmitry Pugachevsky, director of research at Quantifi, explores why building an accurate and robust interest rate curve has considerable implications for a broad range of financial operations – from setting benchmark rates to managing risk – and hinges on…

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here